We participated to the EATRIS annual meeting in Lisbon and presented our work. We thank all the team for their great work and their commitment in this infrastructure.
EMI and SW presented posters and oral presentations about the activities of the translational unit, more specifically:
EMI: "Dissecting anti-tumour T-cell responses in vaccinated long- term surviving glioblastoma patients" (selected for oral presentation)
SW: "Preclinical development of an anti-CD37CAR to treat B-cell malignancies" and an oral presentation: "Enhanced immunotherapeutic tools through EATRIS-network"